<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00274339</url>
  </required_header>
  <id_info>
    <org_study_id>LPR-04-01</org_study_id>
    <nct_id>NCT00274339</nct_id>
  </id_info>
  <brief_title>Prevacid vs Lifestyle Modifications for the Treatment of LPR</brief_title>
  <official_title>A Comparison of Prevacid 30mg BID Plus Lifestyle Modifications Versus Lifestyle Modifications Alone for the Treatment of Laryngopharyngeal Reflux (LPR) in Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hodge, Kenneth M., M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>TAP Pharmaceutical Products Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hodge, Kenneth M., M.D.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate changes in scores on the Reflux Finding Score and
      Reflux Symptom Index over a 24 week period. To enroll subjects must score at least a 13 on
      the Reflux Symptom Index and at least a 5 on the Reflux Finding Score. All subjects will
      receive education on lifestyle modifications with a nutritionist and exercise trainer. All
      subjects will be expected to comply with lifestyle modifications for the entire study period
      of 24 weeks. Half of all subjects will receive Prevacid 30mg BID and half will receive
      placebo BID for 24 weeks. Subjects will have 4 office visits over 24 weeks and weekly
      contacts with the study staff to assess Reflux Symptom Index and any health or medication
      changes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The results of studies evaluating PPI therapy versus lifestyle modifications for the
      treatment of LPR have not been conclusive. However, many of these studies were conducted at
      tertiary care centers. We will look at patients presenting with LPR symptoms in a community
      setting. All subjects will have an exam of their larynx via laryngoscopy at each of the 4
      study visits (screening, week 6, week 12, and week 24). Based on exam findings, the physician
      will complete the Reflux Finding Score. The subjects will also complete the Reflux Symptom
      Index weekly to assess for changes in their symptoms. The statistical analysis of this study
      will include evaluating changes in the Reflux Finding Scores and Reflux Symptom Index scores
      over the 24 weeks of study participation.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2005</start_date>
  <completion_date type="Anticipated">June 2008</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To compare the numbers of subjects with a Reflux Symptom Index score of less than 13 at visit 3</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To evaluate the changes in Reflux Finding Score and Reflux Symptom Index from initial scores at screening to final assessment at visit 3.</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">135</enrollment>
  <condition>Laryngopharyngeal Reflux</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Prevacid 30mg BID</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Lifestyle changes of exercise and diet changes for weight loss and avoidance of reflux inducing foods.</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Symptoms of LPR for at least one month, Score of 5 or greater on Reflux Finding Score,
        Score of 13 or greater on Reflux Symptom Index, and Willing to follow lifestyle
        modifications.

        Exclusion Criteria:

        Currently taking PPI twice daily for the treatment of LPR, Women who are pregnant or
        lactating, History of duodenal or gastric ulcer in the past 5 years, erosive esophagitis,
        or esophageal obstruction, History of any hypersecretory condition, History of Barrett's
        esophagus, History of hematemesis in the past 6 months, Currently taking ketoconazole,
        digoxin, Iron, ampicillin, theophylline, warfarin, or sucralfate, or Suspected disease of
        the larynx not related to LPR.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenneth M Hodge, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Commonwealth Ear, Nose &amp; Throat</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marti Gardner, MSN</last_name>
    <phone>502-893-0159</phone>
    <phone_ext>1185</phone_ext>
    <email>mgardner@commonwealthent.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Commonwealth Ear, Nose &amp; Throat</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marti Gardner, MSN</last_name>
      <phone>502-893-0159</phone>
      <phone_ext>1185</phone_ext>
      <email>mgardner@commonwealthent.com</email>
    </contact>
    <investigator>
      <last_name>Kenneth M Hodge, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>John R Morris, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Donald V Welsh, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gorden T McMurry, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrew R Gould, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Keith D Forwith, PhD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Steven D Shotts, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tamalynn O'Daniel, MSN, ARNP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jolene H Boswell, PA-C</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mary S McLaughlin, PA-C</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Martha L Gardner, MSN, ARNP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brian Walker, PA-C</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index (RSI). J Voice. 2002 Jun;16(2):274-7.</citation>
    <PMID>12150380</PMID>
  </reference>
  <reference>
    <citation>Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding score (RFS). Laryngoscope. 2001 Aug;111(8):1313-7.</citation>
    <PMID>11568561</PMID>
  </reference>
  <reference>
    <citation>Belafsky PC, Postma GN, Amin MR, Koufman JA. Symptoms and findings of laryngopharyngeal reflux. Ear Nose Throat J. 2002 Sep;81(9 Suppl 2):10-3. Review.</citation>
    <PMID>12353425</PMID>
  </reference>
  <reference>
    <citation>Cohen JT, Bach KK, Postma GN, Koufman JA. Clinical manifestations of laryngopharyngeal reflux. Ear Nose Throat J. 2002 Sep;81(9 Suppl 2):19-23. Review.</citation>
    <PMID>12353427</PMID>
  </reference>
  <reference>
    <citation>Koufman JA. Laryngopharyngeal reflux 2002: a new paradigm of airway disease. Ear Nose Throat J. 2002 Sep;81(9 Suppl 2):2-6. Review.</citation>
    <PMID>12353428</PMID>
  </reference>
  <reference>
    <citation>Koufman JA. Laryngopharyngeal reflux is different from classic gastroesophageal reflux disease. Ear Nose Throat J. 2002 Sep;81(9 Suppl 2):7-9. Review.</citation>
    <PMID>12353431</PMID>
  </reference>
  <reference>
    <citation>Postma GN, Belafsky PC, Aviv JE, Koufman JA. Laryngopharyngeal reflux testing. Ear Nose Throat J. 2002 Sep;81(9 Suppl 2):14-8. Review.</citation>
    <PMID>12353426</PMID>
  </reference>
  <reference>
    <citation>Postma GN, Johnson LF, Koufman JA. Treatment of laryngopharyngeal reflux. Ear Nose Throat J. 2002 Sep;81(9 Suppl 2):24-6. Review.</citation>
    <PMID>12353429</PMID>
  </reference>
  <reference>
    <citation>Vaezy, M &amp; Postma, GN. Laryngopharyngeal Reflux from an ENT and GI Perspective Course. October 21, 2004. Louisville, KY.</citation>
  </reference>
  <verification_date>June 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 6, 2006</study_first_submitted>
  <study_first_submitted_qc>January 6, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 10, 2006</study_first_posted>
  <last_update_submitted>June 22, 2007</last_update_submitted>
  <last_update_submitted_qc>June 22, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 25, 2007</last_update_posted>
  <keyword>Laryngopharyngeal Reflux</keyword>
  <keyword>Prevacid</keyword>
  <keyword>Lifestyle changes</keyword>
  <keyword>Reflux Finding Score</keyword>
  <keyword>Reflux Symptom Index</keyword>
  <keyword>Laryngoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
    <mesh_term>Laryngopharyngeal Reflux</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lansoprazole</mesh_term>
    <mesh_term>Dexlansoprazole</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>January 23, 2009</submitted>
    <returned>February 19, 2009</returned>
    <submitted>February 25, 2009</submitted>
    <returned>March 26, 2009</returned>
    <submitted>June 18, 2009</submitted>
    <returned>August 4, 2009</returned>
    <submitted>August 5, 2009</submitted>
    <returned>September 1, 2009</returned>
    <submitted>September 3, 2009</submitted>
    <returned>September 18, 2009</returned>
    <submitted>September 25, 2009</submitted>
    <returned>October 30, 2009</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

